(Q38214140)

31 August 2017

title

Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure (English)

1 reference

31 August 2017

1 reference

12

1 reference

31 August 2017

2

Adrian Covic

1 reference

31 August 2017

10

Raymond Vanholder

1 reference

31 August 2017

9

Patrick Rossignol

1 reference

31 August 2017

Alberto Ortiz

1

0 references

Andrzej Więcek

11

object named as

Andrzej Wiecek

1 reference

31 August 2017

4

Denis Fouque

1 reference

31 August 2017

8

Ziad A Massy

1 reference

31 August 2017

6

Mehmet Kanbay

1 reference

31 August 2017

7

Francesca Mallamaci

1 reference

31 August 2017

Danilo Fliser

3

1 reference

31 August 2017

David Goldsmith

5

1 reference

31 August 2017

Gérard M London

13

1 reference

31 August 2017

Board of the EURECA-m Working Group of ERA-EDTA

14

1 reference

31 August 2017

language of work or name

English

0 references

publication date

1 May 2014

1 reference

31 August 2017

1 reference

31 August 2017

volume

383

1 reference

31 August 2017

issue

9931

1 reference

31 August 2017

page(s)

1831-1843

1 reference

The gap between estimated incidence of end-stage renal disease and use of therapy

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Lifetime risk of ESRD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Cardiovascular and noncardiovascular mortality among patients starting dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Survival patterns of patients on maintenance hemodialysis for end stage renal disease in Ethiopia: summary of 91 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Sudden cardiac death in hemodialysis patients: an in-depth review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Mortality due to pulmonary embolism, myocardial infarction, and stroke among incident dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Survival pattern of hemodialysis patients in Kumasi, Ghana: a summary of forty patients initiated on hemodialysis at a new hemodialysis unit.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Pulmonary infectious mortality among patients with end-stage renal disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Cancer in patients on dialysis for end-stage renal disease: an international collaborative study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Exploring the association between macroeconomic indicators and dialysis mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Associations of frequency and duration of patient-doctor contact in hemodialysis facilities with mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Nephrology in Africa--not yet uhuru

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Mortality risk among children initially treated with dialysis for end-stage kidney disease, 1990-2010.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

UK Renal Registry 15th annual report: Chapter 5 survival and causes of death of UK adult patients on renal replacement therapy in 2011: national and centre-specific analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Secular trends in cardiovascular mortality rates of patients receiving dialysis compared with the general population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Normal and pathologic concentrations of uremic toxins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Vascular access morbidity and mortality: trends of the last decade

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Update on the long-term complications of renal transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Chronic kidney disease: a clinical model of premature aging

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Suppression of aging in mice by the hormone Klotho

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Klotho deficiency causes vascular calcification in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

The inflammatory cytokines TWEAK and TNFα reduce renal klotho expression through NFκB.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Atherosclerosis and arteriosclerosis in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Arterial stiffness and pulse pressure in CKD and ESRD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Accelerated atherosclerosis in prolonged maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Bone-vascular cross-talk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Vascular calcification

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

The expanding spectrum of biological actions of vitamin D.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Sympathetic overactivity in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Aspects of immune dysfunction in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Clinical epidemiology of pneumonia in hemodialysis patients: the USRDS waves 1, 3, and 4 study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Septicemia in the United States dialysis population, 1991 to 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Cancer risk among elderly persons with end-stage renal disease: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Estimated radiation exposure from medical imaging in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Onconephrology: the latest frontier in the war against kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Functional status of elderly adults before and after initiation of dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Cardiovascular protection with antihypertensive drugs in dialysis patients: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Antioxidants for chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Homocysteine-lowering therapy does not lead to reduction in cardiovascular outcomes in chronic kidney disease patients: a meta-analysis of randomised, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Antiplatelet agents for chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Effects of telmisartan added to Angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Spironolactone reduces cardiovascular and cerebrovascular morbidity and mortality in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Effect of membrane permeability on survival of hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Intradialytic parenteral nutrition does not improve survival in malnourished hemodialysis patients: a 2-year multicenter, prospective, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

A randomized, controlled trial of early versus late initiation of dialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Hemodiafiltration: clinical evidence and remaining questions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

In-center hemodialysis six times per week versus three times per week

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Mineralocorticoid receptor antagonists in patients with end-stage renal disease on chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Bicarbonate therapy for prevention of chronic kidney disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Low protein diets for chronic kidney disease in non diabetic adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Nutrition and chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

GFR at initiation of dialysis and mortality in CKD: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Does the adequacy parameter Kt/V(urea) reflect uremic toxin concentrations in hemodialysis patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Survival among nocturnal home haemodialysis patients compared to kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Directed differentiation of human pluripotent cells to ureteric bud kidney progenitor-like cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

How safe is renal replacement therapy? A national study of mortality and adverse events contributing to the death of renal replacement therapy recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

beta-Blocker use in long-term dialysis patients: association with hospitalized heart failure and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Hemoglobin A(1c) levels and mortality in the diabetic hemodialysis population: findings from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Chronic kidney disease as cause of cardiovascular morbidity and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

The randomized registry trial--the next disruptive technology in clinical research?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Reimbursement of dialysis: a comparison of seven countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Cost of peritoneal dialysis and haemodialysis across the world

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Prevalence of chronic kidney disease in Kinshasa: results of a pilot study from the Democratic Republic of Congo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Analysis of the costs of dialysis and the effects of an incentive mechanism for low-cost dialysis modalities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Timing of arteriovenous fistula placement and Medicare costs during dialysis initiation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

LDL cholesterol in CKD--to treat or not to treat?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

Prevention of chronic diseases: a call to action

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960384-6

7 January 2021

10.1016/S0140-6736(14)60384-6

Identifiers

DOI

1 reference

release_b3dwy7dc6bfelcrbgag3vpsaqm

31 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/b3dwy7dc6bfelcrbgag3vpsaqm

24 November 2022

mapped directly with Wikidata item

1 reference